TY - JOUR
T1 - Effects of adjuvant hyperbaric oxygen therapy and real-Time fluorescent imaging on deep sternal wound infection
T2 - A retrospective study
AU - Li, Tse Hsi
AU - Lin, Cheng Hsin
AU - Peng, Chung Kan
AU - Wu, Yi Chun
AU - Hsieh, Tsung Cheng
AU - Lee, Chi Hung
AU - Liu, Yung Ching
AU - Huang, Kun Lun
AU - Tam, Ka Wai
AU - Chang, Shun Cheng
N1 - Publisher Copyright:
© 2025 MA Healthcare Ltd. All rights reserved.
PY - 2025/1/2
Y1 - 2025/1/2
N2 - Objective: Deep sternal wound infection (DSWI) is a rare but devastating complication that is estimated to occur in 1–2% of patients after median sternotomy. Current standard of care (SoC) comprises antibiotics, debridement and negative pressure wound therapy (NPWT). Hyperbaric oxygen therapy (HBOT) appears to be an effective adjuvant therapy for osteomyelitis. The aim of this study was to determine the effectiveness of HBOT and real‑time fluorescence imaging (RTFI) in a DSWI treatment protocol and their benefits on infection control. Method: A retrospective analysis of DSWI management was performed. Enrolled patients were divided into two groups: HBOT group and RTFI group. Patients in the HBOT group received SoC, HBOT, NPWT and reconstructive flap surgery. Patients in the RTFI group received the same therapeutic plan as well as treatment with a RTFI device (MolecuLight i:X (MolecuLight, Inc., Canada) to achieve high-quality debridement. Infection status and short-term outcomes within three months were measured. Long-term outcomes were analysed at a 12-month follow-up. Results: Of the 55 patients enrolled: 22 in the HBOT group and 33 in the RTFI group. Infection control status, evaluated in terms of white blood cell counts and C-reactive protein levels, antibiotic use duration, antibiotic costs, reinfection rate and osteomyelitis recurrence rate, were statistically significantly improved in the RTFI group (<0.001, <0.001, 0.042, 0.022, 0.049 and 0.022, respectively). Length of total intensive care unit stay and duration of complete healing were statistically significantly decreased in the RTFI group (<0.001 and 0.046, respectively). Conclusion: Patients with DSWI can benefit from HBOT, especially in terms of in-hospital mortality. RTFI can be used to eliminate bacterial burden and achieve high-quality debridement, which considerably improves infection control and clinical outcomes.
AB - Objective: Deep sternal wound infection (DSWI) is a rare but devastating complication that is estimated to occur in 1–2% of patients after median sternotomy. Current standard of care (SoC) comprises antibiotics, debridement and negative pressure wound therapy (NPWT). Hyperbaric oxygen therapy (HBOT) appears to be an effective adjuvant therapy for osteomyelitis. The aim of this study was to determine the effectiveness of HBOT and real‑time fluorescence imaging (RTFI) in a DSWI treatment protocol and their benefits on infection control. Method: A retrospective analysis of DSWI management was performed. Enrolled patients were divided into two groups: HBOT group and RTFI group. Patients in the HBOT group received SoC, HBOT, NPWT and reconstructive flap surgery. Patients in the RTFI group received the same therapeutic plan as well as treatment with a RTFI device (MolecuLight i:X (MolecuLight, Inc., Canada) to achieve high-quality debridement. Infection status and short-term outcomes within three months were measured. Long-term outcomes were analysed at a 12-month follow-up. Results: Of the 55 patients enrolled: 22 in the HBOT group and 33 in the RTFI group. Infection control status, evaluated in terms of white blood cell counts and C-reactive protein levels, antibiotic use duration, antibiotic costs, reinfection rate and osteomyelitis recurrence rate, were statistically significantly improved in the RTFI group (<0.001, <0.001, 0.042, 0.022, 0.049 and 0.022, respectively). Length of total intensive care unit stay and duration of complete healing were statistically significantly decreased in the RTFI group (<0.001 and 0.046, respectively). Conclusion: Patients with DSWI can benefit from HBOT, especially in terms of in-hospital mortality. RTFI can be used to eliminate bacterial burden and achieve high-quality debridement, which considerably improves infection control and clinical outcomes.
UR - http://www.scopus.com/inward/record.url?scp=85215351110&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85215351110&partnerID=8YFLogxK
U2 - 10.12968/jowc.2022.0095
DO - 10.12968/jowc.2022.0095
M3 - Article
C2 - 39797755
AN - SCOPUS:85215351110
SN - 0969-0700
VL - 34
SP - 48
EP - 58
JO - Journal of wound care
JF - Journal of wound care
IS - 1
ER -